{
  "content": "Ö Åkerborg et al.\n\nCost-effectiveness of dronedarone in atrial fibrillation: results for Canada, Italy, Sweden, and Switzerland\nClin Ther (2012)\n\nX.R. Sun et al.\n\nRadiofrequency catheter ablation versus cryoballoon ablation in the treatment of paroxysmal atrial fibrillation: a cost-effectiveness analysis in China\nClin Ther (2019)\n\nJ. Ming et al.\n\nCost-effectiveness of cryoballoon ablation versus radiofrequency ablation for paroxysmal atrial fibrillation in China: results based on real-world data\nValue Health (2019)\n\nS. Doyle et al.\n\nPCV136 Health state utility values for atrial fibrillation and associated treatment-related adverse events\nValue in Health (2009)\n\nM. Hu et al.",
  "source": "https://www.sciencedirect.com/science/article/abs/pii/S0149291825002176",
  "chunk_id": "84189092-e17c-4d26-9250-530d81f30375",
  "similarity_score": 0.29762017726898193,
  "query": "cost effectiveness economic analysis amiodarone beta-blockers atrial fibrillation healthcare costs hospitalization reduction",
  "rank": 12,
  "title": "Cost-Effectiveness of Antiarrhythmic Drugs for Treating Paroxysmal or Persistent Atrial Fibrillation in China: An Economic Evaluation",
  "authors": "Fuming Li, Dunming Xiao, Yu Xia, Junling Weng, Shimeng Liu, Yingyao Chen",
  "year": "2025",
  "journal": "Clinical Therapeutics",
  "reference": "Li, F., Xiao, D., Xia, Y., Weng, J., Liu, S., & Chen, Y. (2025). Cost-effectiveness of antiarrhythmic drugs for treating paroxysmal or persistent atrial fibrillation in China: An economic evaluation. Clinical Therapeutics. https://doi.org/Not available",
  "doi": "Not available",
  "chunk_index": 21,
  "total_chunks": 30,
  "retrieved_at": "2025-07-24T21:58:16.915749"
}